Clinical Features of Patients With B-CLL
| Patient . | Stage Binet . | Sex/Age . | Treatment . |
|---|---|---|---|
| CLL-1 | A | M/60 | No |
| CLL-2 | A | M/60 | No |
| CLL-3 | C | M/68 | 6× NOSTE*, 6× IMVP16 |
| CLL-4 | A | F/72 | No |
| CLL-5 | A | F/82 | No |
| CLL-6 | C | M/59 | No |
| CLL-7 | A | M/68 | No |
| CLL-8 | A | M/77 | No |
| CLL-9 | A | M/66 | No |
| CLL-10 | C | F/61 | IFNα, 15× KNOSPE, 6× CLL-CHOP, 3× Fludarabin |
| CLL-11 | C | F/49 | 6× Fludarabin, 1× VAD, 1× IEV |
| CLL-12 | A | M/62 | No |
| Patient . | Stage Binet . | Sex/Age . | Treatment . |
|---|---|---|---|
| CLL-1 | A | M/60 | No |
| CLL-2 | A | M/60 | No |
| CLL-3 | C | M/68 | 6× NOSTE*, 6× IMVP16 |
| CLL-4 | A | F/72 | No |
| CLL-5 | A | F/82 | No |
| CLL-6 | C | M/59 | No |
| CLL-7 | A | M/68 | No |
| CLL-8 | A | M/77 | No |
| CLL-9 | A | M/66 | No |
| CLL-10 | C | F/61 | IFNα, 15× KNOSPE, 6× CLL-CHOP, 3× Fludarabin |
| CLL-11 | C | F/49 | 6× Fludarabin, 1× VAD, 1× IEV |
| CLL-12 | A | M/62 | No |
Mitoxantrone/predmustine